查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2086953

下一代手術機器人：市場洞察、競爭格局與市場預測（2034 年）

Next Generation Surgical Robotics - Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

下一代手術機器人市場概述

概述：

  • 預計到 2025 年，下一代手術機器人市場規模將達到 112 億美元，到 2034 年將達到 385 億美元。這一成長是由微創手術需求的增加、挑戰長期市場主導地位的新興競爭平台以及人工智慧、力回饋和數位手術生態系統的整合所推動的。
  • 全球下一代手術機器人市場預計在 2026 年至 2034 年的預測期內將以 14.7% 的複合年成長率成長。
  • 按組件分類，「儀器和配件」細分市場預計到 2025 年將佔市場佔有率的 52%，從而推動下一代手術機器人市場的發展。
  • 按應用領域分類，預計到 2025 年，一般外科手術領域將佔 31% 的市場佔有率，從而推動下一代手術機器人市場的發展。
  • 從技術角度來看，人工智慧輔助機器人系統領域預計到 2025 年將佔市場佔有率的 58%，從而推動下一代手術機器人市場的發展。
  • 按最終用戶分類，預計到 2025 年，醫院領域將引領市場，佔下一代手術機器人市場佔有率的 72%。
  • 預計到 2025 年，北美將以 56% 的銷售額引領全球下一代手術機器人市場，在全球區域市場佔有率中佔最高地位。

新一代手術機器人是指最新一代的機器人輔助手術平台，它結合了多臂或模組化機械臂、高清3D可視化、人工智慧驅動的影像處理和導航、力反饋和觸覺反饋以及協作式數位手術軟體，能夠以更高的精度、靈活性和控制力進行微創手術。與傳統系統不同，這些平台優先考慮門診環境下的便攜性和模組化設計，其特點是整合了力回饋、自主功能、影像診斷和分析能力、「機器人即服務（RaaS）」經營模式，並針對特定手術類型（包括軟組織手術和整形外科）進行了客製化設計。該市場涵蓋機器人系統和硬體、器械和配件、服務和軟體，並廣泛應用於一般外科、泌尿系統、婦科、整形外科、神經外科、心血管外科等專科。這些平台包括多孔和單孔軟組織機器人、整形外科和脊椎導航機器人、神經外科系統以及新興的腔內和血管內機器人，它們正部署在醫院和門診手術中心。在微創手術興起、人口老化、目前機器人手術在整體手術中應用率較低、新型競爭平台層出不窮以及人工智慧、力回饋和數位手術技術的快速發展等因素的推動下，下一代手術機器人已成為醫療技術領域最具活力和戰略意義的前沿領域之一。

下一代手術機器人市場的關鍵市場促進因素

  • 微創手術具有切口更小、身體負擔更輕、恢復更快、併發症更少等優點，其需求日益成長，推動了醫院機器人輔助手術計畫的擴展。
  • 目前，機器人手術的普及率相對於手術總數而言仍然較低，在大型手術室中，機器人手術僅佔手術總量的一小部分。因此，機器人手術仍有很大的成長空間。
  • Medtronic的「Hugo」、CMR Surgical公司的「Versius」、Distalmotion公司的「Dexter」以及強生公司的「Ottava」等新的競爭平台層出不窮，擴大了選擇範圍，加速了普及應用。
  • 隨著全球癌症和慢性疾病負擔的加重，手術數量也在增加。國際癌症研究機構 (IARC) 預測，癌症患者人數將從 2022 年的 2,000 萬人增加到 2050 年的 3,500 萬人。
  • 人工智慧、力回饋、 3D視覺化和數位手術分析的融合正在提高手術精度、治療效果和外科醫生培訓水平。
  • 在緊湊、模組化的「機器人即服務 (RaaS)」平台的支援下，向門診手術中心的過渡已將實施範圍擴大到大型醫院之外。
  • 對微創手術的需求、競爭平台的出現、人工智慧的整合以及門診手術的擴展，預計將推動微創手術產業在 2034 年前保持兩位數的穩定成長。

推動下一代手術機器人市場成長的因素

市場促進因素

對微創手術的需求日益成長

推動下一代手術機器人市場發展的最強動力是微創手術需求的不斷成長。與開放性手術和傳統腹腔鏡手術相比，機器人輔助平台具有更高的精準度、操控性、3D可視化和人體工學優勢，能夠實現更小的切口、更少的出血、更低的併發症率、更短的住院時間和更快的康復。患者越來越傾向於選擇微創手術，而外科醫生也能從中受益，在長時間、複雜的手術中減少疲勞和身體負擔。機器人輔助手術目前已在泌尿系統、婦科和普通外科中廣泛應用，其中機器人輔助根治性前列腺切除術、子宮切除術和結直腸手術的數量正在穩步成長。隨著臨床證據的累積和治療效果的改善，醫院正在擴大其機器人輔助手術項目，並擴大機器人輔助手術的範圍。這種由患者和外科醫生偏好驅動的、向微創、技術驅動型手術的持續轉變，將在整個預測期內支撐市場持續成長。

滲透率低，且未開發的病例數龐大。

推動成長的主要因素之一是目前機器人手術在所有手術中的普及率較低，這意味著其市場仍有巨大的成長空間。產業分析顯示，僅在美國，每年數百萬例大規模手術中，機器人輔助手術僅佔一小部分，而在許多國際市場，普及率甚至更低。隨著新一代平台降低成本、縮小面積並擴大可開展的手術範圍，軟組織手術、整形外科手術和專科手術的比例正在不斷提高。適應症的擴大、治療結果數據的累積以及保險報銷體系的完善，正穩步推動著傳統手術方式向機器人手術的轉變。低普及率和大量尚未開發的手術需求意味著，即使普及率略有提高，也將帶來顯著的市場成長。因此，隨著機器人手術從少數複雜病例的治療手段發展成為標準手術技術，預計在整個預測期內，市場將保持兩位數的穩定成長。

市場限制因素

儘管發展勢頭強勁，但新一代手術機器人市場仍面臨許多限制因素。機器人系統的高成本是一大障礙，需要對設備、器械、配件、服務合約和設施建設進行大量投資，這限制了小規模醫院、門診手術中心和低收入國家醫療機構的採用，而使其主要集中在資金雄厚的大規模醫療機構。此外，陡峭的學習曲線以及對專業培訓和認證的需求也延緩了機器人手術的普及，因為外科醫生和手術室團隊需要達到較高的熟練程度才能充分發揮機器人手術的優勢和效率。不同地區和不同手術類型的保險報銷仍然存在差異，當臨床獲益甚微時，很難證明機器人手術相對於傳統手術方式的額外成本是合理的，從而限制了投資回報率（ROI）。監管和臨床檢驗要求延長了研發週期，並要求嚴格的安全性和有效性證據。持續的軟體和人工智慧更新也需要持續的上市後監測。手術室工作流程、影像系統和醫院資訊科技（IT）的整合日益複雜，而連網平台上的資料隱私和網路安全問題也加劇了這個難題。現有領導領導企業的壟斷地位和高昂的轉換成本，即使競爭日益激烈，也阻礙了新進入者的競爭。維護、停機時間和對專有耗材的依賴推高了營運成本。成本、培訓、報銷、監管和整合等方面的障礙，儘管存在微創手術需求旺盛、普及率低以及技術創新等強勁的潛在促進因素，但這些因素共同作用，減緩了行業成長速度。

可以從以下幾個方面評估競爭格局：

  • 市場集中：市場整合程度日益加劇，直覺外科公司在軟組織機器人領域佔主導地位。此外，由於資金、臨床證據以及對現有設備的依賴等因素，市場進入門檻很高。
  • 主要公司包括 Intuitive Surgical、Medtronic、Johnson & Johnson MedTech、Stryker 和 Zimmer Biomet，它們構成了頂級公司。
  • 地理擴張：領導企業經營全球銷售、培訓和服務網路，同時開發快速擴張的項目，瞄準亞​​太地區和新興市場。
  • 產品系列優勢：領先企業提供涵蓋軟組織和整形外科機器人、手術器械和數位手術軟體的綜合產品組合。
  • 產品線優勢：擁有活躍的產品線，正在開發單孔、模組化、門診手術平台、力回饋、自主功能和新的專科適應症。
  • 策略合作夥伴關係：正在透過與電腦、醫學影像和健康技術領域的合作夥伴以及與醫院培訓計畫的合作，擴大業務範圍和能力。
  • 併購活動：產業重組仍在繼續，包括 KARL STORZ 收購 Asensus Surgical 和強生公司領先收購 Auris Health。
  • 製造能力：大規模的系統和設備製造能力，以及在大規模安裝方面的豐富經驗，是重要的競爭優勢，也是供應鏈的關鍵考量。
  • 創新重點：人工智慧和力回饋、用於門診護理的模組化和可攜式平台、機器人即服務 (RaaS) 模型以及數位手術生態系統。

下一代手術機器人市場報告要點。

  • 對下一代手術機器人市場的當前市場規模（2025 年）進行分析，並進行 9 年市場預測（2026 年至 2034 年）。
  • 過去三年發生的重大產品和技術開發、合併、收購、合作和合資企業。
  • 引領全球下一代手術機器人市場的領導企業。
  • 下一代手術機器人市場為競爭者提供了各種各樣的商機。
  • 哪些細分市場在2025年表現最佳？這些細分市場在2034年的表現又會如何？
  • 目前哪些地區、國家在新一代手術機器人市場表現最佳？
  • 企業應該將精力集中在哪些地區或國家，才能抓住下一代手術機器人市場的成長機會？

本報告針對下一代手術機器人市場的主要讀者。

  • 提供下一代手術機器人產品的公司
  • 研究機構和顧問公司
  • 與下一代手術機器人相關的組織、協會、論壇和其他相關團體
  • 政府機構和公司
  • 新創公司、創業投資、私募股權公司
  • 銷售代理商和公司負責銷售下一代手術機器人
  • 這個市場面向各種終端用戶，他們希望了解更多關於下一代手術機器人市場及其最新技術趨勢的資訊。

常問問題：

問題1：下一代手術機器人市場的成長率是多少？

預計從 2026 年到 2034 年的預測期內，下一代手術機器人市場將以 14.7% 的複合年成長率成長。

Q2. 下一代手術機器人市場的市場規模有多大？

預計到 2025 年，下一代手術機器人的市場規模將達到 112 億美元，到 2034 年將達到 385 億美元。

Q3.哪些地區正在推動下一代手術機器人市場的發展？

北美地區擁有全球最高的機器人手術普及率、高度集中的製造商、健全的保險報銷體系、大量的手術以及FDA批准數量的激增，預計主導下一代手術機器人市場，到2025年將佔全球銷售額的56%。亞太地區預計將在整個預測期內成為成長最快的地區。

第四季：下一代手術機器人市場的主要促進因素是什麼？

主要促進因素包括：對微創手術的需求不斷成長；目前機器人手術在總手術量中的滲透率較低；Medtronic、CMR Surgical、Distal Motion 和強生等公司推出新的競爭平台；癌症和慢性疾病負擔日益加重（國際癌症研究機構 (IARC) 預測，癌症患者人數將從 2022 年的 2000 萬增加到 300 萬萬）；以及在門診治療趨勢下，人工智慧、力回饋和數位手術的融合。

Q5. 下一代手術機器人市場的主要參與者有哪些？

主要廠商包括 Intuitive Surgical, Inc.、Medtronic plc、Johnson & Johnson MedTech、Stryker Corporation、Zimmer Biomet Holdings, Inc.、Smith & Nephew plc、CMR Surgical Ltd.、Globus Medical、Ascensus Surgical 和 Accuray。此外，如「競爭格局」部分所述，其他主要製造商以及 Distalmotion、Moon Surgical 和 PROCEPT BioRobotics 等新興企業也正在進入市場。 Intuitive Surgical 是軟組織機器人領域的領導者，而 Stryker 和 Zimmer Biomet 則是整形外科機器人領域的領導者。

目錄

第1章：下一代手術機器人市場報告簡介

  • 調查範圍
  • 市場區隔
  • 市場假設

第2章：下一代手術機器人市場摘要整理

  • 市場概覽

第3章：下一代手術機器人市場關鍵因素分析

  • 下一代手術機器人市場：市場促進因素
    • 對微創手術的需求日益成長
    • 低採用率和大未探索的手術病例
    • 新競爭平台的激增和核准的不斷獲得
    • 人工智慧、力回饋、數位手術
  • 下一代手術機器人市場的市場限制與挑戰
    • 系統成本高且保險報銷金額波動較大。
    • 培訓、學習曲線和認證
    • 與監管、整合和網路安全相關的障礙
  • 下一代手術機器人市場：市場機遇
    • 門診手術中心和機器人即服務
    • 拓展至新的專業領域和新興市場

第4章 影響分析：人工智慧、地緣政治、貿易和經濟趨勢

第5章：監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章：下一代手術機器人市場：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭公司之間的競爭

第7章：下一代手術機器人市場評估

  • 按組件
    • 設備和配件
    • 機器人系統和硬體
    • 服務和軟體
  • 用途別
    • 一般外科
    • 泌尿系統
    • 婦科
    • 整形外科
    • 神經外科
    • 心血管及其他
  • 透過技術
    • 人工智慧輔助機器人系統
    • 半自動自主系統
    • 自主系統
  • 最終用戶
    • 醫院
    • 門診手術中心
    • 專科診所及其他
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 世界其他地區

第8章：下一代手術機器人市場的競爭格局

  • 市場集中度與結構
  • 競爭定位與市場佔有率分析（加值服務）

第9章：下一代手術機器人市場的新創企業資金籌措與投資趨勢

第10章 下一代手術機器人市場：公司概況與產品概況

  • Intuitive Surgical, Inc.
    • 公司簡介
    • 公司簡介
    • 財務概覽
    • 產品系列
    • 策略舉措/熵
  • Medtronic plc
  • Johnson & Johnson MedTech
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Smith & Nephew plc
  • CMR Surgical Ltd.
  • Globus Medical, Inc.
  • Asensus Surgical, Inc.
  • Accuray Incorporated

第11章：KOL的觀點

第12章：專案式教學方法

第13章：關於 DelveInsight

第14章 免責聲明與聯絡方式

Product Code: DIMDCL0940

Next Generation Surgical Robotics Market Summary

Overview:

  • The Next Generation Surgical Robotics market is estimated at USD 11.20 billion in 2025 and is projected to reach USD 38.50 billion by 2034. Growth is anchored in the rising demand for minimally invasive surgery, a wave of new competitive platforms challenging long-standing market dominance, and the integration of AI, force feedback, and digital surgery ecosystems.
  • The global Next Generation Surgical Robotics market is growing at a CAGR of 14.7% during the forecast period from 2026 to 2034.
  • By component, the instruments and accessories segment dominated the Next Generation Surgical Robotics market with a 52% share in 2025.
  • By application, the general surgery segment dominated the Next Generation Surgical Robotics market with a 31% share in 2025.
  • By technology, the AI-assisted robotic systems segment dominated the Next Generation Surgical Robotics market with a 58% share in 2025.
  • By end user, the hospitals segment dominated the Next Generation Surgical Robotics market with a 72% share in 2025.
  • North America dominated the global Next Generation Surgical Robotics market revenue with a 56% share in 2025, representing the highest regional market share globally.

Next generation surgical robotics refers to the latest wave of robot-assisted surgical platforms that combine multi-arm or modular manipulators, high-definition three-dimensional visualization, AI-driven imaging and navigation, force and haptic feedback, and connected digital-surgery software to perform minimally invasive procedures with enhanced precision, dexterity, and control. Distinct from earlier systems, these platforms emphasize portability and modularity for ambulatory settings, force feedback and autonomy features, integration with imaging and analytics, robot-as-a-service commercial models, and procedure-specific designs across soft-tissue and orthopedic surgery. The market combines robotic systems and hardware, instruments and accessories, and services and software, applied across general surgery, urology, gynecology, orthopedics, neurosurgery, and cardiovascular and other specialties. Platforms span multiport and single-port soft-tissue robots, orthopedic and spine navigation robots, neurosurgical systems, and emerging endoluminal and endovascular robots, deployed across hospitals and ambulatory surgical centers. Driven by rising minimally invasive surgery, an aging population, a low current penetration of robotics in total surgical volume, a surge of new competitive platforms, and rapid advances in AI, force feedback, and digital surgery, next generation surgical robotics has become one of the most dynamic and strategically important frontiers in medical technology.

Next Generation Surgical Robotics Market Key Growth Drivers

  • Rising demand for minimally invasive surgery, which offers smaller incisions, less trauma, faster recovery, and fewer complications, is driving hospitals to expand robotic-assisted surgery programs.
  • A low current penetration of robotics in total surgical volume, with only a small share of major operating-room procedures performed robotically, leaves substantial room for growth.
  • A surge of new competitive platforms, including Medtronic's Hugo, CMR Surgical's Versius, Distalmotion's Dexter, and Johnson & Johnson's Ottava, is expanding choice and accelerating adoption.
  • The rising global burden of cancer and chronic disease, with the International Agency for Research on Cancer projecting cancer cases to rise from 20 million in 2022 to 35 million by 2050, is increasing surgical volumes.
  • Integration of AI, force feedback, three-dimensional visualization, and digital-surgery analytics is improving precision, outcomes, and surgeon training.
  • The shift toward ambulatory surgical centers, supported by compact, modular, and robot-as-a-service platforms, is broadening adoption beyond large hospitals.
  • The convergence of minimally invasive demand, competitive platform launches, AI integration, and outpatient expansion is expected to sustain strong double-digit growth through 2034.

Key Companies in Next Generation Surgical Robotics Market

The competitive landscape is led by the following active manufacturers and developers:

  • Intuitive Surgical, Inc.
  • Medtronic plc
  • Johnson & Johnson MedTech
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Smith & Nephew plc
  • CMR Surgical Ltd.
  • Globus Medical, Inc.
  • Asensus Surgical, Inc.
  • Accuray Incorporated

Factors Contributing to the Growth of the Next Generation Surgical Robotics Market

Market Drivers

Rising Demand for Minimally Invasive Surgery

The most powerful driver of the Next Generation Surgical Robotics market is the rising demand for minimally invasive surgery. Robotic-assisted platforms deliver superior precision, dexterity, three-dimensional visualization, and ergonomics compared with open and conventional laparoscopic techniques, enabling smaller incisions, less blood loss, reduced complication rates, shorter hospital stays, and faster recovery. Patients increasingly prefer minimally invasive options, and surgeons benefit from reduced fatigue and physical strain over long, complex procedures. Robotic surgery is now well established in urology, gynecology, and general surgery, with steady increases in robotically performed prostatectomies, hysterectomies, and colorectal procedures. As clinical evidence accumulates and outcomes improve, hospitals expand robotic programs and broaden the range of procedures performed robotically. This durable shift toward minimally invasive, technology-enabled surgery, reinforced by patient and surgeon preference, anchors sustained market growth through the forecast period.

Low Penetration and Large Untapped Surgical Volume

A central growth driver is the low current penetration of robotics in total surgical volume, which leaves a vast runway for expansion. Industry analyses indicate that of the millions of major operating-room procedures performed each year in the United States alone, only a small share are robot-assisted, and penetration is lower still in many international markets. As next generation platforms lower cost, reduce footprint, and broaden procedure menus, a growing proportion of soft-tissue, orthopedic, and specialty procedures becomes addressable. Expanding clinical indications, accumulating outcomes data, and improving reimbursement steadily convert conventional procedures to robotic approaches. This combination of low penetration and large untapped volume means that even incremental adoption translates into substantial market growth, supporting strong double-digit expansion across the forecast period as robotics moves from a minority of complex cases toward a standard surgical modality.

Market Restraints

Despite strong momentum, the Next Generation Surgical Robotics market faces material constraints. The high cost of robotic systems is the primary barrier, as capital equipment, instruments, accessories, service contracts, and facility requirements represent a substantial financial investment that limits adoption among smaller hospitals, ambulatory centers, and providers in lower-income countries, concentrating use in larger, better-funded institutions. A steep learning curve and the need for specialized training and credentialing slow deployment, as surgeons and operating-room teams must develop proficiency before procedural benefits and efficiency are realized. Reimbursement remains uneven across geographies and procedures, and the incremental cost of robotic surgery over conventional approaches can be difficult to justify where clinical advantage is marginal, constraining the return on investment. Regulatory and clinical-validation requirements lengthen development timelines and demand rigorous evidence of safety and benefit, while ongoing software and AI updates require continued post-market oversight. Integration with operating-room workflows, imaging systems, and hospital information technology adds complexity, and concerns about data privacy and cybersecurity in connected platforms add further burden. The dominance of an established leader and high switching costs create barriers for new entrants, even as competition intensifies. Maintenance, downtime, and dependence on proprietary consumables add operational cost. Together, these cost, training, reimbursement, regulatory, and integration barriers temper the pace of growth, even as the underlying drivers of minimally invasive demand, low penetration, and technological innovation remain firmly intact.

Next Generation Surgical Robotics Market Segment Analysis

The Next Generation Surgical Robotics Market by Component (Instruments and Accessories, Robotic Systems and Hardware, Services and Software), Application (General Surgery, Urology, Gynecology, Orthopedics, Neurosurgery, Cardiovascular and Others), Technology (AI-Assisted Robotic Systems, Semi-Autonomous Systems, Autonomous Systems), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Others), and Geography (North America, Europe, Asia-Pacific, Rest of World).

By Component

Dominant Subsegment: Instruments and Accessories. The instruments and accessories category is expected to dominate the market.

Dominant: Instruments and Accessories ~ 52%

The instruments and accessories segment accounted for 52% of the Next Generation Surgical Robotics market in 2025. Instruments and accessories are the leading component because surgical robotics operates on a razor-and-blade model in which each procedure consumes endoscopes, energy instruments, staplers, drapes, and single-use accessories, producing recurring revenue that scales directly with procedure volume. As the installed base of robotic systems grows and procedure counts rise into the millions annually, consumable demand deepens with every case, and market leaders derive a large and growing share of revenue from instruments and services rather than one-time system sales. Manufacturers reinforce this dynamic by pairing proprietary platforms with closed-system instruments, locking institutions into ongoing purchases. The expansion of procedure menus, the entry of new platforms each with their own consumables, and the shift toward single-use instruments further enlarge the segment. While robotic systems and hardware anchor the installed base and services and software capture digital and support revenue, the recurring economics and procedure-linked growth of instruments and accessories secure the segment's leadership across the forecast period.

By Application

Dominant Subsegment: General Surgery. The general surgery category is expected to dominate the market.

Dominant: General Surgery ~ 31%

The general surgery segment accounted for 31% of the Next Generation Surgical Robotics market in 2025. General surgery is the leading application because it encompasses the broadest and highest-volume set of robotic procedures, including hernia repair, cholecystectomy, colorectal, bariatric, and foregut surgery, performed across a wide range of hospitals and increasingly ambulatory centers. The breadth of general-surgery indications and the steady conversion of laparoscopic and open procedures to robotic approaches give the segment the largest revenue base, and most new competitive platforms target general surgery to maximize their addressable market. Urology and gynecology remain large, established robotic specialties, anchored by high robotic penetration in prostatectomy and hysterectomy, while orthopedics, led by robotic joint replacement and spine navigation, is a major and fast-growing segment. Neurosurgery and cardiovascular applications expand with navigation and emerging endovascular robotics. Nonetheless, the scale, breadth, and ongoing conversion of high-volume procedures secure general surgery's leadership across the forecast period.

By End User

Dominant Subsegment: Hospitals. The hospitals category is expected to dominate the market.

Dominant: Hospitals ~ 72%

The hospitals segment accounted for 72% of the Next Generation Surgical Robotics market in 2025. Hospitals are the largest end user because they perform the overwhelming majority of complex surgical procedures and have the capital, infrastructure, surgical specialties, and case volume to acquire and operate premium robotic platforms. Academic medical centers and large hospitals anchor the installed base for high-value systems from Intuitive Surgical, Medtronic, Johnson & Johnson, Stryker, and Zimmer Biomet, and they support the training, credentialing, and throughput that robotic programs require. Hospital adoption is reinforced by the breadth of procedures, established reimbursement, and the ability to absorb high upfront system and service costs. At the same time, ambulatory surgical centers are the fastest-growing end user, propelled by a 2026 reimbursement change that moves procedures to outpatient settings and by compact, modular, and robot-as-a-service platforms designed for them, while specialty clinics expand access. Nonetheless, the volume, acuity, and infrastructure of hospitals secure their clear leadership across the forecast period.

Next Generation Surgical Robotics Market Region Analysis

Dominant Region: North America

North America accounted for 56% of the global Next Generation Surgical Robotics market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects the world's highest robotic surgery adoption, advanced healthcare infrastructure, strong reimbursement, high surgical volumes, and the concentration of leading manufacturers, particularly in the United States. North America hosts the headquarters and primary markets of Intuitive Surgical, Medtronic, Johnson & Johnson MedTech, Stryker, and Zimmer Biomet, ensuring strong training, support, and instrument supply. The region benefits from a wave of FDA clearances, including Medtronic's Hugo, CMR Surgical's Versius Plus, and Distalmotion's Dexter, and from a Medicare reimbursement change effective in 2026 that accelerates the movement of procedures into ambulatory surgical centers. Intuitive Surgical's large installed base and continued investment, including manufacturing and training expansion, anchor regional leadership. Deep clinical expertise, supportive regulation, and strong investment sustain North America's continued leadership across the forecast period.

Dominant: North America ~ 56% (Largest)

Fastest Growing Region: Asia-Pacific

Asia-Pacific is the fastest-growing region in the Next Generation Surgical Robotics market. The region's elevated CAGR is driven by a large and aging population, rising cancer and chronic-disease burden, expanding healthcare access, and strong government support for medical robotics across China, Japan, India, South Korea, and Australia. China's national strategies have fueled investment in domestic surgical robotics, and Chinese manufacturers are developing cost-effective platforms that narrow performance gaps, while India expands access through hospital partnerships and training programs in tier-two and tier-three cities. Rising surgical volumes, growing medical tourism, and increasing affordability of robotic systems accelerate adoption across the region. Local innovation, lower-cost platforms, and government initiatives position Asia-Pacific as the principal source of incremental growth over the forecast period.

Regional Commentary

North America

North America accounted for 56% of the global Next Generation Surgical Robotics market revenue in 2025. The United States dominates on the strength of the world's highest robotic surgery adoption, a dense base of manufacturers, strong reimbursement, high surgical volumes, FDA clearance momentum, and a 2026 reimbursement change accelerating outpatient robotic surgery, while Canada contributes through hospital adoption and provincial programs.

Europe

Europe is a large and advanced regional market, led by Germany, the United Kingdom, France, Italy, and Spain. Growth is supported by strong healthcare systems, government hospital-digitalization funding such as Germany's Hospital Future Act and France's health-innovation strategy, and a robust manufacturer base including CMR Surgical, Distalmotion, KARL STORZ, and Smith & Nephew, while national health-technology assessment shapes adoption.

Asia-Pacific

Asia-Pacific is the fastest-growing region, propelled by a large aging population, rising cancer and chronic-disease burden, expanding healthcare access, and strong government support for medical robotics across China, Japan, India, South Korea, and Australia. Domestic manufacturers scale cost-effective platforms, while hospital partnerships, training centers, and medical tourism broaden access.

Rest of World

The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. A rising burden of cancer and chronic disease, expanding hospital infrastructure, and growing demand for minimally invasive surgery are increasing adoption, while partnerships, training programs, lower-cost platforms, and robot-as-a-service models are gradually extending access to surgical robotics across these markets.

Next Generation Surgical Robotics Market Competitive Landscape

The Next Generation Surgical Robotics market is classified as Consolidated. Intuitive Surgical holds a dominant position in soft-tissue robotics through its da Vinci platform, with the top players collectively controlling the large majority of revenue, followed by Medtronic, Johnson & Johnson MedTech, Stryker, and Zimmer Biomet across soft-tissue and orthopedic robotics. A rapidly expanding field of challengers, including CMR Surgical, Distalmotion, Moon Surgical, PROCEPT BioRobotics, and SS Innovations, is intensifying competition as new platforms reach the market, particularly in ambulatory and cost-sensitive segments.

The competitive landscape can be evaluated across the following dimensions:

  • Market concentration: Consolidated, with Intuitive Surgical dominant in soft-tissue robotics and high barriers to entry from capital, clinical evidence, and installed-base lock-in.
  • Leading players: Intuitive Surgical, Medtronic, Johnson & Johnson MedTech, Stryker, and Zimmer Biomet anchor the top tier.
  • Geographic reach: Leaders operate global commercial, training, and service networks, with rapid expansion programs targeting Asia-Pacific and emerging markets.
  • Product portfolio strength: Top players offer integrated portfolios spanning soft-tissue and orthopedic robots, instruments, and digital-surgery software.
  • Pipeline strength: Active pipelines in single-port, modular, and outpatient platforms, force feedback, autonomy features, and new specialty indications.
  • Strategic partnerships: Collaborations with computing, imaging, and health-technology partners, and hospital training programs, extend reach and capability.
  • M&A activity: Consolidation continues, including KARL STORZ's acquisition of Asensus Surgical and Johnson & Johnson's earlier acquisition of Auris Health.
  • Manufacturing capabilities: Scale manufacturing of systems and instruments and large installed bases are key competitive moats and supply-chain considerations.
  • Innovation focus: AI and force feedback, modular and portable platforms for ambulatory care, robot-as-a-service models, and digital-surgery ecosystems.

Next Generation Surgical Robotics Market Recent Developmental Activities

In December 2025, Medtronic plc, received FDA clearance of the Hugo robotic-assisted surgery system for urologic procedures, supported by the Expand URO study, becoming the first large medtech company to introduce a soft-tissue surgical robot in the United States since the da Vinci. Strategic significance: Establishes a major competitor to Intuitive Surgical and expands hospital choice in soft-tissue robotics.

In December 2025, CMR Surgical Ltd., received FDA 510(k) clearance for its Versius Plus system to perform cholecystectomy and posted nine-figure financing to support United States commercialization. Strategic significance: Adds a modular, portable robotic platform and broadens access beyond academic medical centers.

Next Generation Surgical Robotics Market Segmentation

Next Generation Surgical Robotics Market by Component

  • Instruments and Accessories
  • Robotic Systems and Hardware
  • Services and Software

Next Generation Surgical Robotics Market by Application

  • General Surgery
  • Urology
  • Gynecology
  • Orthopedics
  • Neurosurgery
  • Cardiovascular and Others

Next Generation Surgical Robotics Market by Technology

  • AI-Assisted Robotic Systems
  • Semi-Autonomous Systems
  • Autonomous Systems

Next Generation Surgical Robotics Market by End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics and Others

Next Generation Surgical Robotics Market by Geography

  • North America Next Generation Surgical Robotics Market
  • United States Next Generation Surgical Robotics Market Size in USD million (2023-2034)
  • Canada Next Generation Surgical Robotics Market Size in USD million (2023-2034)
  • Mexico Next Generation Surgical Robotics Market Size in USD million (2023-2034)
  • Europe Next Generation Surgical Robotics Market
  • Germany Next Generation Surgical Robotics Market Size in USD million (2023-2034)
  • United Kingdom Next Generation Surgical Robotics Market Size in USD million (2023-2034)
  • France Next Generation Surgical Robotics Market Size in USD million (2023-2034)
  • Italy Next Generation Surgical Robotics Market Size in USD million (2023-2034)
  • Spain Next Generation Surgical Robotics Market Size in USD million (2023-2034)
  • Rest of Europe Next Generation Surgical Robotics Market Size in USD million (2023-2034)
  • Asia-Pacific Next Generation Surgical Robotics Market
  • China Next Generation Surgical Robotics Market Size in USD million (2023-2034)
  • Japan Next Generation Surgical Robotics Market Size in USD million (2023-2034)
  • India Next Generation Surgical Robotics Market Size in USD million (2023-2034)
  • Australia Next Generation Surgical Robotics Market Size in USD million (2023-2034)
  • South Korea Next Generation Surgical Robotics Market Size in USD million (2023-2034)
  • Rest of Asia-Pacific Next Generation Surgical Robotics Market Size in USD million (2023-2034)
  • Rest of the World (RoW) Next Generation Surgical Robotics Market
  • Middle East Next Generation Surgical Robotics Market Size in USD million (2023-2034)
  • Africa Next Generation Surgical Robotics Market Size in USD million (2023-2034)
  • South America Next Generation Surgical Robotics Market Size in USD million (2023-2034)

Key Takeaways from the Next Generation Surgical Robotics Market Report Study

  • Market size analysis for the current next generation surgical robotics market size (2025), and market forecast for 9 years (2026 to 2034).
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
  • Key companies dominating the global next generation surgical robotics market.
  • Various opportunities available for competitors in the next generation surgical robotics market space.
  • What are the top-performing segments in 2025? How will these segments perform in 2034?
  • Which are the top-performing regions and countries in the current next generation surgical robotics market scenario?
  • Which are the regions and countries where companies should concentrate their opportunities for next generation surgical robotics market growth in the future?

Target audience who can benefit from this next generation surgical robotics market report study

  • Next Generation Surgical Robotics product providers
  • Research organizations and consulting companies
  • Next Generation Surgical Robotics-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in next generation surgical robotics
  • Various end-users who want to know more about the next generation surgical robotics market and the latest technological developments in the next generation surgical robotics market.

Frequently Asked Questions:

Q1. What is the growth rate of the Next Generation Surgical Robotics market?

The Next Generation Surgical Robotics market is projected to expand at a CAGR of 14.7% during the forecast period from 2026-2034.

Q2. What is the market size of the Next Generation Surgical Robotics market?

The Next Generation Surgical Robotics market is estimated at USD 11.20 billion in 2025 and is projected to reach USD 38.50 billion by 2034.

Q3. Which region dominates the Next Generation Surgical Robotics market?

North America dominated the Next Generation Surgical Robotics market with a 56% share of global revenue in 2025, supported by the world's highest robotic surgery adoption, a dense base of manufacturers, strong reimbursement, high surgical volumes, and a wave of FDA clearances. Asia-Pacific is the fastest-growing region over the forecast period.

Q4. What are the key drivers of the Next Generation Surgical Robotics market?

The principal drivers are rising demand for minimally invasive surgery; the low current penetration of robotics in total surgical volume; a surge of new competitive platforms from Medtronic, CMR Surgical, Distalmotion, and Johnson & Johnson; the rising burden of cancer and chronic disease, with the International Agency for Research on Cancer projecting cancer cases to rise from 20 million in 2022 to 35 million by 2050; and the integration of AI, force feedback, and digital surgery, reinforced by the shift to ambulatory settings.

Q5. Who are the major players in the Next Generation Surgical Robotics market?

The major players include Intuitive Surgical, Inc., Medtronic plc, Johnson & Johnson MedTech, Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, CMR Surgical Ltd., Globus Medical, Inc., Asensus Surgical, Inc., and Accuray Incorporated, among other active manufacturers profiled in the Competitive Landscape section, along with emerging players such as Distalmotion, Moon Surgical, and PROCEPT BioRobotics. Intuitive Surgical leads soft-tissue robotics, while Stryker and Zimmer Biomet lead orthopedic robotics.

Table of Contents

1. Next Generation Surgical Robotics Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumptions

2. Next Generation Surgical Robotics Market Executive Summary

  • 2.1 Market at a Glance

3. Next Generation Surgical Robotics Market Key Factors Analysis

  • 3.1 Next Generation Surgical Robotics Market Drivers
    • 3.1.1 Rising Demand for Minimally Invasive Surgery
    • 3.1.2 Low Penetration and Large Untapped Surgical Volume
    • 3.1.3 Surge of New Competitive Platforms and Clearances
    • 3.1.4 AI, Force Feedback, and Digital Surgery
  • 3.2 Next Generation Surgical Robotics Market Restraints and Challenges
    • 3.2.1 High System Cost and Reimbursement Variability
    • 3.2.2 Training, Learning Curve, and Credentialing
    • 3.2.3 Regulatory, Integration, and Cybersecurity Barriers
  • 3.3 Next Generation Surgical Robotics Market Opportunities
    • 3.3.1 Ambulatory Surgical Centers and Robot-as-a-Service
    • 3.3.2 New Specialties and Emerging-Market Expansion

4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments

5. Regulatory Analysis

  • 5.1 United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Next Generation Surgical Robotics Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Buyers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Next Generation Surgical Robotics Market Assessment

  • 7.1 By Component
    • 7.1.1 Instruments and Accessories
    • 7.1.2 Robotic Systems and Hardware
    • 7.1.3 Services and Software
  • 7.2 By Application
    • 7.2.1 General Surgery
    • 7.2.2 Urology
    • 7.2.3 Gynecology
    • 7.2.4 Orthopedics
    • 7.2.5 Neurosurgery
    • 7.2.6 Cardiovascular and Others
  • 7.3 By Technology
    • 7.3.1 AI-Assisted Robotic Systems
    • 7.3.2 Semi-Autonomous Systems
    • 7.3.3 Autonomous Systems
  • 7.4 By End User
    • 7.4.1 Hospitals
    • 7.4.2 Ambulatory Surgical Centers
    • 7.4.3 Specialty Clinics and Others
  • 7.5 By Geography
    • 7.5.1 North America
      • 7.5.1.1 United States Next Generation Surgical Robotics Market Size in USD million (2023-2034)
      • 7.5.1.2 Canada Next Generation Surgical Robotics Market Size in USD million (2023-2034)
      • 7.5.1.3 Mexico Next Generation Surgical Robotics Market Size in USD million (2023-2034)
    • 7.5.2 Europe
      • 7.5.2.1 Germany Next Generation Surgical Robotics Market Size in USD million (2023-2034)
      • 7.5.2.2 United Kingdom Next Generation Surgical Robotics Market Size in USD million (2023-2034)
      • 7.5.2.3 France Next Generation Surgical Robotics Market Size in USD million (2023-2034)
      • 7.5.2.4 Italy Next Generation Surgical Robotics Market Size in USD million (2023-2034)
      • 7.5.2.5 Spain Next Generation Surgical Robotics Market Size in USD million (2023-2034)
      • 7.5.2.6 Rest of Europe Next Generation Surgical Robotics Market Size in USD million (2023-2034)
    • 7.5.3 Asia-Pacific
      • 7.5.3.1 China Next Generation Surgical Robotics Market Size in USD million (2023-2034)
      • 7.5.3.2 Japan Next Generation Surgical Robotics Market Size in USD million (2023-2034)
      • 7.5.3.3 India Next Generation Surgical Robotics Market Size in USD million (2023-2034)
      • 7.5.3.4 Australia Next Generation Surgical Robotics Market Size in USD million (2023-2034)
      • 7.5.3.5 South Korea Next Generation Surgical Robotics Market Size in USD million (2023-2034)
      • 7.5.3.6 Rest of Asia-Pacific Next Generation Surgical Robotics Market Size in USD million (2023-2034)
    • 7.5.4 Rest of World
      • 7.5.4.1 Middle East Next Generation Surgical Robotics Market Size in USD million (2023-2034)
      • 7.5.4.2 Africa Next Generation Surgical Robotics Market Size in USD million (2023-2034)
      • 7.5.4.3 South America Next Generation Surgical Robotics Market Size in USD million (2023-2034)

8. Next Generation Surgical Robotics Market Competitive Landscape

  • 8.1 Market Concentration and Structure
  • 8.2 Competitive Positioning and Market Share Analysis (Premium Offering)

9. Next Generation Surgical Robotics Market Startup Funding and Investment Trends

10. Next Generation Surgical Robotics Market Company and Product Profiles

  • 10.1 Intuitive Surgical, Inc.
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Portfolio
    • 10.1.5 Strategic Initiatives / Entropy
  • 10.2 Medtronic plc
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Portfolio
    • 10.2.5 Strategic Initiatives / Entropy
  • 10.3 Johnson & Johnson MedTech
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Portfolio
    • 10.3.5 Strategic Initiatives / Entropy
  • 10.4 Stryker Corporation
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Portfolio
    • 10.4.5 Strategic Initiatives / Entropy
  • 10.5 Zimmer Biomet Holdings, Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Portfolio
    • 10.5.5 Strategic Initiatives / Entropy
  • 10.6 Smith & Nephew plc
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Portfolio
    • 10.6.5 Strategic Initiatives / Entropy
  • 10.7 CMR Surgical Ltd.
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Portfolio
    • 10.7.5 Strategic Initiatives / Entropy
  • 10.8 Globus Medical, Inc.
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Portfolio
    • 10.8.5 Strategic Initiatives / Entropy
  • 10.9 Asensus Surgical, Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Portfolio
    • 10.9.5 Strategic Initiatives / Entropy
  • 10.10 Accuray Incorporated
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Portfolio
    • 10.10.5 Strategic Initiatives / Entropy

For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer and Contact Us

List of Tables

  • Table 1: Next Generation Surgical Robotics Market in Global (2023-2034)
  • Table 2: Next Generation Surgical Robotics Market in Global by Component (2023-2034)
  • Table 3: Next Generation Surgical Robotics Market in Global by Application (2023-2034)
  • Table 4: Next Generation Surgical Robotics Market in Global by Technology (2023-2034)
  • Table 5: Next Generation Surgical Robotics Market in Global by End User (2023-2034)
  • Table 6: Next Generation Surgical Robotics Market in Global by Geography (2023-2034)
  • Table 7: Next Generation Surgical Robotics Market in North America (2023-2034)
  • Table 8: Next Generation Surgical Robotics Market in the United States (2023-2034)
  • Table 9: Next Generation Surgical Robotics Market in Canada (2023-2034)
  • Table 10: Next Generation Surgical Robotics Market in Mexico (2023-2034)
  • Table 11: Next Generation Surgical Robotics Market in Europe (2023-2034)
  • Table 12: Next Generation Surgical Robotics Market in Germany (2023-2034)
  • Table 13: Next Generation Surgical Robotics Market in United Kingdom (2023-2034)
  • Table 14: Next Generation Surgical Robotics Market in France (2023-2034)
  • Table 15: Next Generation Surgical Robotics Market in Italy (2023-2034)
  • Table 16: Next Generation Surgical Robotics Market in Spain (2023-2034)
  • Table 17: Next Generation Surgical Robotics Market in the Rest of Europe (2023-2034)
  • Table 18: Next Generation Surgical Robotics Market in Asia-Pacific (2023-2034)
  • Table 19: Next Generation Surgical Robotics Market in China (2023-2034)
  • Table 20: Next Generation Surgical Robotics Market in Japan (2023-2034)
  • Table 21: Next Generation Surgical Robotics Market in India (2023-2034)
  • Table 22: Next Generation Surgical Robotics Market in Australia (2023-2034)
  • Table 23: Next Generation Surgical Robotics Market in South Korea (2023-2034)
  • Table 24: Next Generation Surgical Robotics Market in Rest of Asia-Pacific (2023-2034)
  • Table 25: Next Generation Surgical Robotics Market in the Rest of the World (2023-2034)
  • Table 26: Next Generation Surgical Robotics Market in the Middle East (2023-2034)
  • Table 27: Next Generation Surgical Robotics Market in Africa (2023-2034)
  • Table 28: Next Generation Surgical Robotics Market in South America (2023-2034)
  • Table 29: Competitive Landscape
  • Table 30: Startup Funding and Investment Trends

List of Figures

  • Figure 1: Next Generation Surgical Robotics Market Drivers
  • Figure 2: Next Generation Surgical Robotics Market Restraints
  • Figure 3: Next Generation Surgical Robotics Market Opportunities
  • Figure 4: Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
  • Figure 5: Regulatory Analysis (US, EU, Japan, China)
  • Figure 6: Porter's Five Forces Analysis
  • Figure 7: Competitive Analysis
  • Figure 8: Next Generation Surgical Robotics Market in Global (2023-2034)
  • Figure 9: Next Generation Surgical Robotics Market in Global by Component (2023-2034)
  • Figure 10: Next Generation Surgical Robotics Market in Global by Application (2023-2034)
  • Figure 11: Next Generation Surgical Robotics Market in Global by Technology (2023-2034)
  • Figure 12: Next Generation Surgical Robotics Market in Global by End User (2023-2034)
  • Figure 13: Next Generation Surgical Robotics Market in Global by Geography (2023-2034)
  • Figure 14: Next Generation Surgical Robotics Market in North America (2023-2034)
  • Figure 15: Next Generation Surgical Robotics Market in the United States (2023-2034)
  • Figure 16: Next Generation Surgical Robotics Market in Canada (2023-2034)
  • Figure 17: Next Generation Surgical Robotics Market in Mexico (2023-2034)
  • Figure 18: Next Generation Surgical Robotics Market in Europe (2023-2034)
  • Figure 19: Next Generation Surgical Robotics Market in Germany (2023-2034)
  • Figure 20: Next Generation Surgical Robotics Market in United Kingdom (2023-2034)
  • Figure 21: Next Generation Surgical Robotics Market in France (2023-2034)
  • Figure 22: Next Generation Surgical Robotics Market in Italy (2023-2034)
  • Figure 23: Next Generation Surgical Robotics Market in Spain (2023-2034)
  • Figure 24: Next Generation Surgical Robotics Market in the Rest of Europe (2023-2034)
  • Figure 25: Next Generation Surgical Robotics Market in Asia-Pacific (2023-2034)
  • Figure 26: Next Generation Surgical Robotics Market in China (2023-2034)
  • Figure 27: Next Generation Surgical Robotics Market in Japan (2023-2034)
  • Figure 28: Next Generation Surgical Robotics Market in India (2023-2034)
  • Figure 29: Next Generation Surgical Robotics Market in Australia (2023-2034)
  • Figure 30: Next Generation Surgical Robotics Market in South Korea (2023-2034)
  • Figure 31: Next Generation Surgical Robotics Market in Rest of Asia-Pacific (2023-2034)
  • Figure 32: Next Generation Surgical Robotics Market in the Rest of the World (2023-2034)
  • Figure 33: Next Generation Surgical Robotics Market in the Middle East (2023-2034)
  • Figure 34: Next Generation Surgical Robotics Market in Africa (2023-2034)
  • Figure 35: Next Generation Surgical Robotics Market in South America (2023-2034)
  • Figure 36: Competitive Landscape
  • Figure 37: Startup Funding and Investment Trends